Advertisement
U.S. Markets open in 9 hrs 2 mins

Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)

NSE - NSE Real Time Price. Currency in INR
60.25-1.03 (-1.68%)
As of 09:47AM IST. Market open.
Currency in INR

Valuation Measures4

Market Cap (intraday) 1.80B
Enterprise Value 2.08B
Trailing P/E 31.72
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.35
Price/Book (mrq)1.35
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA 18.32

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 374.80
52 Week Low 337.35
50-Day Moving Average 365.94
200-Day Moving Average 353.04

Share Statistics

Avg Vol (3 month) 3144.81k
Avg Vol (10 day) 332.14k
Shares Outstanding 528.35M
Implied Shares Outstanding 6N/A
Float 813.66M
% Held by Insiders 151.13%
% Held by Institutions 12.62%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 1.10%
Operating Margin (ttm)0.56%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.72B
Revenue Per Share (ttm)180.53
Quarterly Revenue Growth (yoy)149.10%
Gross Profit (ttm)N/A
EBITDA 42.72M
Net Income Avi to Common (ttm)51.98M
Diluted EPS (ttm)2.00
Quarterly Earnings Growth (yoy)71.00%

Balance Sheet

Total Cash (mrq)28.9M
Total Cash Per Share (mrq)1.03
Total Debt (mrq)313.52M
Total Debt/Equity (mrq)23.61
Current Ratio (mrq)N/A
Book Value Per Share (mrq)47.33

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A